Social media should connect patients with doctors

Share this article:
One definition of social media is public conversation between private individuals. Now apply this to the most important health issue you've ever faced and you see the daunting challenge the FDA contends with in setting social media marketing guidelines. Health literacy, privacy preferences and lifestyle all impact how people interpret social interactions online. What may seem educational for the masses could be persuasive to the individual facing a health issue.

Pharma can and should join the digital movement, but there's obvious hesitation given the recent backlash by the FDA. From where I sit, we need further industry understanding of how consumers are already using the web for health because the web is fundamentally different from the television medium that so many in our industry remain wedded to.

Pew Internet's report from June 2009, “The Social Life of Health Information,” provides data from which we can work. It reports that 61% of American adults look online for health information. Yet, “social networking sites are used only sparingly for health queries and updates.” We're happy to Google symptoms, but we're not likely to update our Facebook status with a psoriasis flare up.

Social media as a patient tool is a powerful channel for encouragement from friends and family. Patients need to be better linked to their doctors, not linked to ever-growing but perhaps irrelevant health content.

Most of the pharma social media programs I see are using the web as TV—it's content aimed at you, but it's not an interaction that is going to bring you better health. It leaves out so much potential because it excludes the person with the greatest personal reputation: the doctor.

Technology has tremendous power to do more than just serve up content to hungry audiences. It has the power to create completely new relationships and experiences. For pharma, technology could reset the entire notion of marketing as a tool of persuasion.

We hope that, in between further FDA guidance about social media and the end of promotional sales, our industry can focus more on marketing that connects patients where and when it matters most: to their doctor while they're on treatment.

Gene Guselli is co-founder, president, CEO, InfoMedics
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.